Mad Money 04/23/26 | Audio Only

Key Concepts

• Parabolic Moves: Stocks that experience rapid, near-vertical price increases in a short period, often signaling unsustainable growth and high risk of a crash.
• Rule of 50: A metric for cloud software companies where the sum of the revenue growth rate and profit margin should exceed 50.
• AI Displacement Risk: The threat that artificial intelligence technologies (e.g., Anthropic, OpenAI) could render existing enterprise software business models obsolete or force price compression.
• Value in Growth: Investing in sectors (like healthcare) that are currently undervalued but possess long-term growth potential.
• Short Squeeze: A rapid increase in a stock's price caused by short sellers being forced to buy back shares to cover their positions.
• Associated Gas: Natural gas produced as a byproduct of oil extraction, which provides a cost advantage for petrochemical producers.

---

1. Market Overview and Sector Rotation

Jim Cramer highlights a shift in market sentiment, noting that while the major averages (Dow, S&P, NASDAQ) faced declines, the "enterprise software" sector is suffering from a "stench" caused by fears of AI displacement.

• Service Now (NOW): Despite reporting a strong quarter that met the "Rule of 50," the stock plummeted 17% (down 44% YTD). Cramer argues that Wall Street is no longer willing to pay a premium multiple for software companies that AI might eventually mimic or undercut on price.
• Healthcare as a Value Play: Cramer advocates for rotating into healthcare stocks that have been "pulverized" but remain fundamentally strong. He identifies these as safer alternatives to tech, as they are less vulnerable to AI displacement.

2. Healthcare Recommendations

Cramer provides specific examples of healthcare stocks he views as undervalued:

• CVS Health (CVS): Trades at ~11x earnings. Cramer likes their ownership of Aetna and their dominant position as competition (like Rite Aid) pulls back.
• Cardinal Health (CAH): Trading at <20x earnings, the company is shifting from a pure drug wholesaler to a service manager for complex medical organizations.
• Johnson & Johnson (JNJ): Boasts a top-tier balance sheet (shared only with Microsoft) and a strong pipeline of potential blockbuster drugs.
• UnitedHealth Group (UNH): Recently reported a "beat and raise" quarter. With CEO Steve Hemsley returning, Cramer views the stock as a "juggernaut" currently trading at an attractive 19x earnings.

3. Industrial and Utility Insights

• Dow (DOW): Benefiting from the closure of the Straits of Hormuz, which tightened global supply for ethylene and polyethylene. CEO Jim Fiddley notes that the supply chain disruption could last several quarters, keeping margins high. Dow is shifting toward a "path to zero" environmental strategy with its Alberta project.
• Thermo Fisher Scientific (TMO): Despite a solid earnings beat and raised guidance, the stock dropped 9.2% due to light short-term guidance. CEO Mark Casper remains confident, citing the "golden age of biology" and AI-enabled instrumentation as long-term growth drivers.
• PG&E (PCG): Cramer views this as a "single-issue" stock (wildfire liability) with a strong growth story. The company is successfully lowering residential rates while adding significant capacity for data centers.

4. The Danger of Parabolic Stocks

Cramer warns investors against holding stocks that have gone "parabolic"—moving straight up without consolidation.

• The Strategy: If a stock is up >50% in a month, investors should "ring the register" by selling at least enough to recoup their cost basis.
• Case Studies:
  • Avis (CAR): A classic short squeeze that soared to $800 before crashing to $229.
  • Mega Fortune: A meme-like stock that rose 2,000% in April; Cramer labels this unsustainable.
  • Lightwave Logic: A speculative stock that doubled in six weeks with little revenue, which Cramer identifies as a prime candidate for profit-taking.

5. Notable Quotes

• "Bears make money, bulls make money, but hogs, they get slaughtered." — Jim Cramer (on the importance of taking profits).
• "I’m not a seller of the future. I’m a buyer of the future." — Jim Cramer (regarding his stance on Tesla and innovation).
• "You don't get a premium multiple if your company's pricing is under pressure." — Jim Cramer (explaining the decline in software valuations).

Synthesis/Conclusion

The market is currently undergoing a painful transition where high-growth software stocks are being re-evaluated due to AI-related risks. Cramer’s actionable advice is to pivot toward high-quality, undervalued healthcare names that offer stability and to exercise extreme discipline with "parabolic" stocks. Investors are urged to prioritize fundamental value over speculative momentum to avoid being "slaughtered" when market sentiment shifts.